American National Bank & Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.2K Buy
33
+20
+154% +$11K ﹤0.01% 430
2026
Q2
$6.84K Buy
13
+1
+8% +$561 ﹤0.01% 519
2026
Q1
$6.74K Buy
+12
New +$7.7K ﹤0.01% 507
2024
Q1
– Sell
-107
Closed -$59.4K – 524
2023
Q4
$59.4K Sell
107
-17
-14% -$7.98K 0.01% 273
2023
Q3
$54.2K Buy
124
+31
+33% +$15.5K 0.01% 274
2023
Q2
$46.7K Hold
93
– – 0.01% 278
2023
Q1
$46.5K Hold
93
– – 0.01% 274
2022
Q4
$38K Sell
93
-3
-3% -$1.17K 0.01% 277
2022
Q3
$31K Sell
96
-54
-36% -$19.8K 0.01% 267
2022
Q2
$53K Sell
150
-10
-6% -$4.08K 0.01% 172
2022
Q1
$88K Buy
160
+25
+19% +$13.2K 0.02% 155
2021
Q4
$89K Buy
135
+8
+6% +$5.02K 0.02% 156
2021
Q3
$79K Buy
127
+10
+9% +$6.72K 0.02% 137
2021
Q2
$74K Buy
117
+101
+631% +$55.8K 0.02% 143
2021
Q1
$8K Buy
+16
New +$8.02K ﹤0.01% 220

Other funds holding IDXX

American National Bank & Trust's IDXX Position: Q3 2026 in Review

American National Bank & Trust increased its Idexx Laboratories (IDXX) stake by 154% in Q3 2026, buying an estimated $11K and bringing the position to 33 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

American National Bank & Trust first reported a position in IDXX in Q1 2021 and has held it in 15 quarters since. The position peaked at $89K in Q4 2021. 33 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • American National Bank & Trust held 33 shares of Idexx Laboratories worth $17.2K as of Q3 2026.
  • American National Bank & Trust bought 20 Idexx Laboratories shares in Q3 2026, an estimated $11K.
  • Idexx Laboratories made up ﹤0.01% of American National Bank & Trust's portfolio in Q3 2026, its #430 holding.
  • American National Bank & Trust first reported a position in Idexx Laboratories in Q1 2021 and has held it in 15 quarters since.
  • American National Bank & Trust's Idexx Laboratories position peaked at $89K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on American National Bank & Trust's 13F filing for Q3 2026, filed 7 Oct 2026.